An Updated Review of Membranous Nephropathy

Area of Science:

• Nephrology
• Immunology
• Genetics

Background:

• Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
• The identification of phospholipase A2 receptor (PLA2R) as a primary target antigen revolutionized MN understanding.
• Over 20 novel target antigens have been discovered, significantly advancing antigen mapping.

Purpose of the Study:

• To provide a comprehensive review of current knowledge on membranous nephropathy.
• To focus on the genetic, immune, and environmental factors contributing to MN.
• To discuss novel target antigens, their clinical associations, and evolving therapeutic strategies.

Main Methods:

• Review of recent literature on membranous nephropathy.
• Analysis of genetic and environmental factors implicated in MN pathogenesis.
• Synthesis of information on novel target antigens and their clinical relevance.
• Evaluation of current and emerging treatment options for MN.

Main Results:

• Serum PLA2R antibodies are crucial for MN diagnosis, prognosis, and treatment guidance.
• New antigens, like nerve epidermal growth factor-like 1, show associations with specific conditions such as malignancies.
• Genome-wide association studies and environmental research are elucidating MN underpinnings.
• Therapeutic approaches have expanded beyond steroids and cyclophosphamide to include rituximab and calcineurin inhibitors.

Conclusions:

• The understanding of MN has significantly advanced due to discoveries in target antigens and their clinical associations.
• Genetic and environmental factors play a critical role in MN pathogenesis.
• Therapeutic options for MN are diversifying, offering improved management strategies.